# Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO)

> **NCT04224103** · — · UNKNOWN · sponsor: **Filio Billia** · enrollment: 10 (estimated)

## Conditions studied

- Extracorporeal Membrane Oxygenation
- Nitric Oxide
- Shock, Cardiogenic

## Interventions

- **DRUG:** Inhaled nitric oxide

## Key facts

- **NCT ID:** NCT04224103
- **Lead sponsor:** Filio Billia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-08
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224103, "Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04224103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*